TORONTO, ON / ACCESSWIRE / March 7, 2024 / Lumira Ventures, a life sciences investment firm dedicated to supporting healthcare innovation and patient impact, is proud to announce several significant ...

During the past 18 months Lumira Ventures completed 8 exit transactions and portfolio companies received 2 FDA new product approvals and raised over US$800M via IPOs and public and private financings ...

Toronto-based Lumira Ventures has raised $276 million CAD ($220 million USD) for Fund IV, which Lumira claims is “the largest institutional life sciences venture capital fund ever raised in Canada.” ...

TORONTO, ON / ACCESSWIRE / January 6, 2022 / Lumira Ventures, a leading North American healthcare venture capital firm, today announced the promotion of Dr. Lu Han, Ph.D., to Partner and the ...

Canadian life sciences fund Lumira Ventures has raised a major tranche of cash as it looks to funnel an extra $220 million into the sector. Its Fund IV also comes with some extra swag: The VC has tied ...

Lumira Ventures has raised the largest Canadian life sciences venture capital fund in two decades, drawing US$220-million from investors. But Lumira managing general partner Peter van der Velden ...

Lumira Ventures, one of Canada’s top investors in private health sciences startups, is launching a hedge fund to bet on publicly traded companies it believes have been oversold during the sector’s ...

TORONTO, ON / ACCESSWIRE / April 2, 2024 / Lumira Ventures is delighted to announce its latest investment in Nocion Therapeutics, a clinical-stage biopharmaceutical company developing first and ...

TORONTO, March 3, 2016 /CNW/ - Lumira Capital, a leading North American health care venture capital firm, today announced that Richard Glickman, Frank Stonebanks and Brian Underdown have been ...

BOSTON & LONDON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp (Nasdaq: CAHC), a special purpose acquisition company focused on investing in a growth-oriented healthcare company which recently ...